2024-25 Seed Grant Awardees
2023-24 Seed Grant Awardees
2022-23 Seed Grant Awardees
2021-22 Seed Grant Awardees
NATHAN DAHL, MD
University of Colorado
PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy
Pediatric - High Grade Gliomas - Treatment
BETTY KIM, MD, PHD
MD Anderson Cancer Center
Microbial-Inspired STING Activation for Glioblastoma Immunotherapy
Glioblastoma - Immunotherapeutic treatments
2020-21 Seed Grant Awardees
MATTHEW WAITKUS, PHD
Duke University
Synthetic lethal strategies for targeting ATRX deficiency and the Alternative Lengthening of Telomeres in Pediatric High-Grade Gliomas
Pediatric - Gliomas
MARGARITA GUTOVA, MD
City of Hope
Overcoming Resistance to CAR T Immunotherapy with CBP/β-catenin Antagonists ICG-001 in BrainTumors: The Road Ahead Towards Metabolic Enhancement of Cancer Immunotherapy
Gliomas and Ependymomas - Treatment
LIOR MAYO, PHD
Tel Aviv University
Targeting Astrocyte Metabolic Reprogramming in Glioblastoma
Glioblastoma - Treatment
2019-20 Seed Grant Awardees
ALBERT LAI, MD, PHD
University of Los Angeles, California
Paracrine effect of glioma metabolism on immune epigenetics
Glioma - Science
FLORIAN MULLER, PHD
MD Anderson Cancer Center
Angiogenesis Inhibited Tumors are Vulnerable to Inhibitor of Oxidative Phosphorylation
Glioblastoma - Treatment
SANTOSH KESARI, MD, PHD
John Wayne Cancer Institute
Optimization of OLIG2 inhibition for Glioblastoma treatment
Glioblastoma - Treatment
2018-19 Seed Grant Awardees
MANISH AGHI, MD, PHD
University of California, San Francisco
Defining and targeting pro-tumoral effects of cancer-associated fibroblasts in glioblastoma
Glioblastoma
SANTOSH KESARI, MD, PHD
John Wayne Cancer Institute
Targeting metabolic reprogramming in pediatric medulloblastoma
Pediatric - Medulloblastoma
FREDERICK F. LANG, MD, FACS, FAANS, FAAAS
MD Anderson Cancer Center
Super-selective Intra-arterial Infusion of Human Mesenchymal Stem Cell-based Therapy in a Rabbit Human Glioblastoma Model
Glioblastoma - Treatment
ELMAR NURMEMMEDOV, PHD
John Wayne Cancer Institute
Targeting inhibition of Beta-catenin in medulloblastoma
Medulloblastoma
2017-18 Seed Grant Awardees
DAVID A. NATHANSON, PHD
University of California, Los Angeles
Comprehensive characterization of apoptotic blocks in Glioblastoma
Glioblastoma
ROBERT M. PRINS, PHD
University of California, Los Angeles
Identification and cloning of neoantigen-specific T Cells for Glioblastoma immunotherapy
Glioblastoma
CHRISTOPHER J. WHEELER, PHD
Cedars-Sinai Medical Center
Combination Immunotherapy and Precision Medicine to treat Glioblastoma
Glioblastoma
JUNBAO YANG, MD, PHD
John Wayne Cancer Institute
Searching the targets on Glioblastoma for immune cells to attack. Specifically, antigen-specific T Cells and antigenic epitope discovery for immunotheraphy
Glioblastoma